EUVIMEDEUVIMED entdecken
Crossref

Structure–Activity Relationship Studies in Benzothiadiazoles as Novel Vaccine Adjuvants

Masiel M Belsuzarri, Yukiya Sako iD, Tyler D Brown, Michael Chan, Renna Cozza, Jasmine Jin, Fumi Sato-Kaneko, Shiyin Yao, Minya Pu, Karen Messer, Tomoko Hayashi iD, Howard B Cottam und 3 weitere

Journal of Medicinal Chemistry · 2024

DOI: 10.1021/acs.jmedchem.4c00491 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Medicinal Chemistry, 2024. Verfasst von Masiel M Belsuzarri und 14 weiteren Autor:innen. Beteiligte Einrichtung: UC San Diego Moores Cancer Center, University of California San Diego, La Jolla, California 92093, United States. Hauptthemen laut MEDLINE: Adjuvants, Immunologic, Thiadiazoles. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 33 Literaturangaben. Gefördert von: NCI NIH HHS, National Institute of Allergy and Infectious Diseases.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Extracellular vesicles (EVs) can transfer antigens and immunomodulatory molecules, and such EVs released by antigen-presenting cells equipped with immunostimulatory functions have been utilized for vaccine formulations. A prior high-throughput screening campaign led to the identification of compound 634 (1), which enhanced EV release and increased intracellular Ca2+ influx. Here, we performed systematic structure-activity relationship (SAR) studies to investigate the scaffold for its potency as a vaccine adjuvant. Synthesized compounds were analyzed in vitro for CD63 reporter activity (a marker for EV biogenesis) in human THP-1 cells, induction of Ca2+ influx, IL-12 production, and cell viability in murine bone-marrow-derived dendritic cells. The SAR studies indicated that the ester functional group was requisite, and the sulfur atom of the benzothiadiazole ring replaced with a higher selenium atom (9f) or a bioisosteric ethenyl group (9h) retained potency. Proof-of-concept vaccination studies validated the potency of the selected compounds as novel vaccine adjuvants.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Adjuvants, ImmunologicThiadiazolesStructure-Activity RelationshipHumansAnimalsMiceDendritic CellsTHP-1 CellsVaccinesMice, Inbred C57BLFemaleExtracellular Vesicles

Substanzen

Adjuvants, ImmunologicThiadiazolesbenzo-1,2,3-thiadiazoleVaccines

Autor:innen und Institutionen

  • UC San Diego Moores Cancer Center, University of California San Diego, La Jolla, California 92093, United States.
  • Department of Medicine, University of California San Diego, La Jolla, California 92093, United States.
  • Division of Biostatistics, Herbert Wertheim School of Public Health and Longevity, University of California San Diego, La Jolla, California 92093, United States.

ORCID-Profile: Yukiya Sako, Tomoko Hayashi, Maripat Corr, Nikunj M Shukla

Förderung

  • NCI NIH HHS
  • National Institute of Allergy and Infectious Diseases

Zitieren

APA

Belsuzarri, M. M., Sako, Y., Brown, T. D., Chan, M., Cozza, R., Jin, J., Sato-Kaneko, F., Yao, S., Pu, M., Messer, K., Hayashi, T., Cottam, H. B., Corr, M., Carson, D. A., & Shukla, N. M. (2024). Structure–Activity Relationship Studies in Benzothiadiazoles as Novel Vaccine Adjuvants. Journal of Medicinal Chemistry. https://doi.org/10.1021/acs.jmedchem.4c00491

Vancouver

Belsuzarri MM, Sako Y, Brown TD, Chan M, Cozza R, Jin J, et al. Structure–Activity Relationship Studies in Benzothiadiazoles as Novel Vaccine Adjuvants. Journal of Medicinal Chemistry. 2024. doi:10.1021/acs.jmedchem.4c00491

BibTeX
@article{Belsuzarri2024,
  author = {Belsuzarri, Masiel M and Sako, Yukiya and Brown, Tyler D and Chan, Michael and Cozza, Renna and Jin, Jasmine and Sato-Kaneko, Fumi and Yao, Shiyin and Pu, Minya and Messer, Karen and Hayashi, Tomoko and Cottam, Howard B and Corr, Maripat and Carson, Dennis A and Shukla, Nikunj M},
  title = {Structure–Activity Relationship Studies in Benzothiadiazoles as Novel Vaccine Adjuvants},
  journal = {Journal of Medicinal Chemistry},
  year = {2024},
  doi = {10.1021/acs.jmedchem.4c00491}
}
Kostenlos starten →